Vistin Pharma ASA: Mandatory notification of trade
Vistin Pharma ASA (VISTN) · publisert 20. februar 2026 kl. 19:31 · vis på NewsWeb
Transaksjoner
| Person | Rolle | Type | Volum | Pris | Dato | ISIN | Handelsplass |
|---|---|---|---|---|---|---|---|
| Magnus Tolleshaug | CEO | Kjøp | 30 000 | 21,1 NOK | 20. februar 2026 | – | – |
Meldingstekst
Magnus Tolleshaug, Chief Executive Officer in Vistin Pharma ASA, and a primary
insider, has on 20'th of February 2026 purchased 30.000 shares in Vistin Pharma
ASA at an average price of NOK 21,10 per share. Following this purchase Magnus
Tolleshaug holds 105.000 shares in Vistin Pharma ASA.